ATRS Antares Pharma Inc

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

$4.39  +0.05 (1.04%)
As of 06/24/2021 15:57:51 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  06/11/2012
Outstanding shares:  168,798,266
Average volume:  1,122,712
Market cap:   $734,272,457
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    036642106
ISIN:        US0366421065
Sedol:      2383163
Valuation   (See tab for details)
PE ratio:   11.75
PB ratio:   5.80
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy